Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board -- Ignore unavailable to you. Want to Upgrade?

To: statesidereport who wrote (452)	5/19/2015 10:23:08 AM
From: ogi	Respond to of 1728

.........and that was an excellent contribution from Diddly to boot . Added to my SVA @ .17, a multi year hold for me thus far. Recently received U.S. patent for their implantable "pouch" which then integrates with the body and blood supply. Once implanted and taking root the pouch can receive donor cells. For now the prime focus is on diabetes, could be applied to multiple conditions, like thyroid and they have an agreement with another co for blood clotting factor. Gene therapy could be revolutionary and the holy grail is their Sertoli cell technology , which if proven would allow these implants to work without the need for anti rejection drug therapy. They are in their first human trial, ingoing for nearly 2 years now and they are being quite tight lipped. Just financed and warrant at a high premium to average trading with an acceleration clause. Hope news starts flowing this summer.